Logo image
Physicians' attitudes and the use of oral anticoagulants: surveying the present and envisioning future
Journal article   Peer reviewed

Physicians' attitudes and the use of oral anticoagulants: surveying the present and envisioning future

Meghan York, Ashish Agarwal, Michael Ezekowitz and Akash Agarwal
Journal of thrombosis and thrombolysis, v 16(1-2), pp 33-37
01 Aug 2003
PMID: 14760209

Abstract

Atrial fibrillation has the highest prevalence in the elderly. While the elderly are at the highest risk for stroke and would benefit the most from anticoagulation, they are also the least likely to receive anticoagulation. In a pooled analysis of the primary prevention trials, warfarin reduced stroke by 68% compared with placebo, and aspirin reduced stroke by 18%. Age, history of hypertension, diabetes, heart failure or reduced left ventricular function, and previous transient ischemic events and stroke are independent risk factors for stroke in patients with atrial fibrillation. Less than 50% of the elderly who have clear-cut indications and no contraindications for warfarin receive anticoagulant therapy. This low use of warfarin is driven by many factors, but physicians' fear of hemorrhage is among the most important. Better adherence to evidence-driven guidelines, better patient and physician education, point-of-care monitoring of INR and the future development of user friendly anticoagulant drugs are likely to result in higher rates of anticoagulation use.

Metrics

11 Record Views
9 citations in Scopus

Details

UN Sustainable Development Goals (SDGs)

This publication has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

InCites Highlights

Data related to this publication, from InCites Benchmarking & Analytics tool:

Web of Science research areas
Cardiac & Cardiovascular Systems
Hematology
Peripheral Vascular Disease
Logo image